Modelling normal tissue toxicity in pancreatic chemoradiotherapy

Modelling normal tissue toxicity in pancreatic chemoradiotherapy

<p>The relationship between radiation dose and toxicity in pancreatic chemoradiotherapy is not well understood. Clinically, excessive normal tissue toxicity is avoided by placing a constraint on the volume of the organ receiving a dose above a threshold. Dose-volume constraints lack spatial...

Bibliografiset tiedot
Päätekijä:	Witztum, A
Muut tekijät:	Hawkins, M
Aineistotyyppi:	Opinnäyte
Julkaistu:	2018

Samankaltaisia teoksia

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
Tekijä: Holyoake, D, et al.
Julkaistu: (2016)

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
Tekijä: Holyoake, DLP, et al.
Julkaistu: (2018)

Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy
Tekijä: Holyoake, D, et al.
Julkaistu: (2017)

EP-1721: Feature extraction from duodenal dose surface maps to predict toxicity in pancreatic chemoradiation
Tekijä: Witztum, A, et al.
Julkaistu: (2016)

[Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis].
Tekijä: Brunner, T
Julkaistu: (2012)

Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
Tekijä: Verbeke, C. S., et al.
Julkaistu: (2006)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
Tekijä: Warren, S, et al.
Julkaistu: (2016)

Characterizing cis-regulatory variation in the transcriptome of histologically normal and tumor-derived pancreatic tissues
Tekijä: Zhang, M, et al.
Julkaistu: (2017)

Using functional imaging to improve chemoradiotherapy outcomes in pancreatic and rectal cancer: moving towards a hypoxia targeting approach
Tekijä: Wilson, J
Julkaistu: (2015)

Investigating the toxicity and safety of radiotherapy for pancreatic cancer
Tekijä: Holyoake, D
Julkaistu: (2018)

Radiosensitation in vivo by histone deacetylase inhibition with no increase in early normal tissue radiation toxicity
Tekijä: Groselj, B, et al.
Julkaistu: (2017)

Radiosensitisation in vivo by histone deacetylase inhibition with no increase in early normal tissue radiation toxicity
Tekijä: Groselj, B, et al.
Julkaistu: (2017)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
Tekijä: Mukherjee, S, et al.
Julkaistu: (2013)

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
Tekijä: Wilson, J, et al.
Julkaistu: (2017)

Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.
Tekijä: Warren, S, et al.
Julkaistu: (2014)

EP-1720: Impact of contouring variability on tumour control and normal tissue toxicity in liver SBRT
Tekijä: Robinson, M, et al.
Julkaistu: (2016)

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients.
Tekijä: Brunner, T, et al.
Julkaistu: (2011)

SU-F-T-108: Texture analysis for toxicity prediction from dose surface maps.
Tekijä: Witztum, A, et al.
Julkaistu: (2016)

Chemoradiotherapy for carcinoma of the oesophagus: Experience of a single institution
Tekijä: Toy, E, et al.
Julkaistu: (2001)

Oesophageal Chemoradiotherapy in the UK-Current Practice and Future Directions
Tekijä: Gwynne, S, et al.
Julkaistu: (2013)

Oesophageal Chemoradiotherapy in the UK--current practice and future directions.
Tekijä: Gwynne, S, et al.
Julkaistu: (2013)

Ultrasound mediated gemcitabine delivery reduces the normal tissue toxicity of chemoradiation therapy in a muscle-invasive bladder cancer model
Tekijä: Ruan, J-L, et al.
Julkaistu: (2021)

Delayed surgical intervention after chemoradiotherapy in esophageal cancer
Tekijä: Chidambaram, S, et al.
Julkaistu: (2023)

Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis | Gemcitabin-basierte Strahlenchemotherapie beim lokal fortgeschrittenen Pankreaskarzinom - eine Metaanalyse
Tekijä: Brunner, T
Julkaistu: (2012)

Correlation of 18F-fluorodeoxyglucose positron emission tomography parameters with patterns of disease progression in locally advanced pancreatic cancer after definitive chemoradiotherapy
Tekijä: Wilson, J, et al.
Julkaistu: (2017)

Modeling of [¹⁸F]-FHBG in tumor and normal tissues
Tekijä: Slutsky, Emily Dale
Julkaistu: (2008)

Irradiation at ultra-high (FLASH) dose rates reduces acute normal tissue toxicity in the mouse gastrointestinal system
Tekijä: Ruan, J-L, et al.
Julkaistu: (2021)

Weight loss in post-chemoradiotherapy head and neck cancer patients
Tekijä: Abu Zaid, Zalina, et al.
Julkaistu: (2022)

Rectal adenocarcinoma with oncocytic features: possible relationship with preoperative chemoradiotherapy.
Tekijä: Rouzbahman, M, et al.
Julkaistu: (2006)

Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.
Tekijä: Sherriff, J, et al.
Julkaistu: (2013)

Pixel-based analysis of stomach dose-surface maps to improve toxicity predictions in gastrointestinal radiotherapy
Tekijä: Witztum, A, et al.
Julkaistu: (2017)

Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck. A retrospective single center analysis.
Tekijä: Balermpas, P, et al.
Julkaistu: (2014)

A radiation damage repair model for normal tissues.
Tekijä: Partridge, M
Julkaistu: (2008)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
Tekijä: Mukherjee, S, et al.
Julkaistu: (2024)

p53 status and the regression of rectal cancer following preoperative chemoradiotherapy
Tekijä: Wheeler, J, et al.
Julkaistu: (2000)

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
Tekijä: Balermpas, P, et al.
Julkaistu: (2014)

Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: The reverse of the Will Rogers phenomenon?
Tekijä: Fokas, E, et al.
Julkaistu: (2015)

Gemcitabine-based chemoradiotherapy in locally advanced pancreas carcinoma - A meta-analysis
Tekijä: Brunner, T
Julkaistu: (2012)

Effect of anaemia prevention on survival and local control in oesophageal cancers treated with chemoradiotherapy.
Tekijä: Tuan, J, et al.
Julkaistu: (2012)

Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: the reverse of the Will Rogers phenomenon?
Tekijä: Fokas, E, et al.
Julkaistu: (2015)